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Introduction: Research has shown that those with attention-deficit/hyperactivity disorder
(ADHD) have an increased risk for addiction disorders like alcoholism and substance abuse.
What is less clear is the mechanism(s) whereby ADHD gives rise to increased engagement
in addictive behaviors, and whether there are sex differences in the ADHD-addiction propen-
sity. Both ADHD and addictions have also been associated with personality traits such as
impulsivity, reward seeking, anxiousness, and negative affect. In this study, we tested a
moderator-mediation model, which predicted that both sex and ADHD-symptom status
would make independent contributions to the variance in personality risk and in addictive
behaviors, with males, and those with diagnosed ADHD, scoring higher on both dependent
variables. Our model also predicted that the effect of sex and ADHD-symptom status on
addictive behaviors would be via the mediating or intervening influence of personality-risk
factors.
Methods: A community-based sample of young men and women took part in the
study. Among these individuals, 46 had received a lifetime diagnosis of ADHD. The non-
diagnosed participants were dichotomized into a high-ADHD-symptom group (n=83) and
a low-symptom group (n=84).
Results: We found that a high-risk personality profile may, in part, account for the rela-
tionship between ADHD symptomatology and the use/abuse of a broad range of addictive
behaviors. However, we found no sex differences in personality risk for addiction or in the
use of addictive behaviors; nor did sex moderate the relationships we assessed.
Conclusion: While ADHD status showed a strong relationship with both dependent
variables in the model, we found no difference between those who had been diag-
nosed with ADHD and treated with stimulants, and their high-symptom non-diagnosed/
non-treated counterparts. These results add support to claims that the treatment of
ADHD with stimulant medication neither protects nor fosters the risk for substance abuse
disorders.
Keywords: attention deficit/hyperactivity disorder, addictive behaviors, personality, sex
INTRODUCTION
Attention-deficit /hyperactivity disorder (ADHD) is a highly her-
itable (≈70%) neuropsychiatric disorder with typical onset in
childhood (1). Furthermore, in a substantial proportion (≈75%)
of cases, ADHD symptoms do not remit in childhood/adolescence
and continue into adulthood (2). It appears, however, that genetic
factors account for a lower heritability in adults with ADHD (≈30–
40%) than in children with this disorder (3, 4). The psychosocial
and behavioral impairments that characterize ADHD are associ-
ated with a number of deleterious outcomes. Perhaps most notably
is the increased risk of substance use and abuse – evidence, which
derives largely from follow-up studies of children and adolescence
with ADHD [e.g., Ref. (5, 6)]. It also seems that this co-morbid
risk is exacerbated in girls (7), and that a common underlying
bio-behavioral process influences both the risk for ADHD and for
substance and alcohol dependence (8). In addition, in a recent
long-term follow-up study, results were relatively consistent with
most previous studies in finding that substance and alcohol abuse
were about six times more likely in cases with ADHD than in
controls, and that females had a significantly higher risk than
males (9).
The ADHD-drug use/abuse link is also evident from the reverse
perspective. It has been estimated that up to 50% of adolescents
and adults with substance abuse disorders have a lifetime diagno-
sis of ADHD (5, 10). For example, ADHD was significantly more
prevalent in methamphetamine abusers compared to control par-
ticipants, especially in those with a persistence of symptoms into
adulthood (11). Research also indicates that the comorbidity of
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substance use disorders and ADHD is associated with a more
severe progression from use to abuse, and with greater social and
psychiatric impairment (12).
In a recent 15-year, longitudinal, population-based ADHD
study, the prevalence of substance abuse/dependence was substan-
tially higher (≈31%), however, for nicotine than for other drugs
like alcohol, cannabis, and cocaine (13). It also appears that the
choice of addictive substance may be affected by the medication
status of the user as seen in a case–control study of medication-
compliant (i.e., methylphenidate or atomoxetine) adolescents. As
anticipated, the ADHD probands were more likely than the con-
trols to be daily smokers (14). However, contrary to expectation,
the control participants reported heavier and more regular use of
alcohol. A weaker link between ADHD symptoms and alcohol use,
compared to that between ADHD and nicotine use, has also been
found in other research (15). Such substance-related differences
were explained, in part, by previous evidence that alcohol has a
synergistic effect on methylphenidate by increasing its potency and
causing feelings of dizziness and discomfort – effects that might
discourage alcohol consumption in some individuals taking this
medication (16).
MEDICATION STATUS AND RISK FOR SUBSTANCE USE/ABUSE
Stimulant medication for ADHD continues to be the first-line
treatment for this disorder in most clinical settings, despite lin-
gering concerns about its potential for abuse and whether it may
sensitize individuals to later problematic substance use (17). Drugs
like methylphenidate and amphetamines block or inhibit the
dopamine and the norepinephrine transporters thereby increas-
ing extracellular levels of these neurotransmitters. Amphetamines
also gain access to the presynaptic terminals and foster the release
of these catecholamines (18). As with all pharmacotherapies, how-
ever, efficacy of the drug varies across individuals and is influenced
by brain neurochemistry and physiology. For instance, in two
human studies, it was found that low levels of the dopamine D2
receptor in the striatum were associated with greater reinforcing
responses to methylphenidate – a factor, which may predispose
individuals with a hypo-functioning dopamine system to the risk
of stimulant drug abuse (19, 20).
In an early meta-analysis of six stimulant-treatment outcome
studies, Wilens and colleagues (21) concluded that pharmacother-
apy for ADHD in childhood actually reduced the likelihood of later
problem drug and alcohol use. However, a more rigorous review,
of a larger body of empirical evidence a decade later, found no
support for the “sensitization hypothesis” of stimulant treatment.
Indeed, neither did it find that stimulant treatment conferred a
protective effect on later substance abuse (17). Recent preclinical
research suggests that inconsistencies in the putative relationship
between stimulant treatment and risk for substance abuse may
be explained by the moderating effects of emotional factors. For
instance, juvenile rats chronically treated with methylphenidate
showed a greater intake of, and preference for, alcohol in adult-
hood, but only in those who were socially isolated by being caged
in solitary housing – an environment known to increase stress and
anxiety in these animals (22).
Sex and age appear to be other factors that moderate the
ADHD-drug use relationship. In a clinical population-based,
birth-cohort study, it was found that childhood ADHD cases were
6.2 times more likely to have an alcohol/drug use disorder than
non-ADHD controls from the same cohort, and that stimulant
treatment tended to be a protective factor, but only in boys (23).
In a more recent prospective arm of the same study, from the same
birth cohort, it was confirmed that ADHD cases diagnosed in ado-
lescence were more likely to have alcohol or drug dependence in
adulthood (24). In other words, as ADHD cases grew to maturity,
they were more likely to use drugs and were more likely to develop
new-onset drug dependence than controls. Importantly, however,
this study found that ADHD cases who had received treatment (for
at least 6 months) after the age of 13 were at greater risk than those
who received treatment before that age. Similarly, Dalsgaard et al.
(9) found that both boys and girls with ADHD were at increased
risk for substance abuse in adulthood, but that early initiation of
stimulant treatment in children resulted in reduced risk compared
to cases with later treatment onset. Nevertheless, there is still not
complete agreement on the relationship between treatment with
psychomotor stimulants and the risk for developing a drug addic-
tion, nor the causal direction of such a putative association. Some
of the outcome inconsistencies may be due to the relatively short
length of follow-up and the high rates of attrition in earlier studies
[e.g., Ref. (25, 26)].
MECHANISMS LINKING ADHD AND SUBSTANCE USE/ABUSE
Although links between ADHD symptomatology and substance
(ab)use are well-documented, there has been little informa-
tion about mechanisms that might foster this connection. One
approach has been to examine the influence of personality traits
associated with both ADHD and substance users in the general
population. In this regard, the very limited ADHD research has
focused largely on facets of impulsivity and their association with
alcohol consumption in this clinical cohort [e.g., Ref. (27)]. Other
research has indicated that the positive relationship between nico-
tine and marijuana use and ADHD-symptom dimensions may also
be mediated by aspects of impulsivity (28). In addition, related
investigations have found that an aversion to delayed gratifica-
tion and an abnormal sensitivity to individual instances of reward
are mediating links between symptoms of ADHD and addictive
behaviors (29). These authors have suggested that a high reward
drive might imply that “dopamine timing is off” in those with
ADHD. Indeed, the pathophysiology of ADHD has mostly been
ascribed to dopamine dysfunctions in the mesocorticolimbic path-
way (30). Imaging studies have shown, for example, that ADHD
patients display in increased availability of the dopamine trans-
porter in this brain region relative to their healthy counterparts
[see Ref. (31) for a review]. While there is other evidence that
ADHD is associated with reduced functionality of the dopamine
system – due in part to reduced receptor densities in various brain
regions compared to non-affected individuals [see Ref. (32, 33)] –
findings are not entirely consistent. For example, some studies
suggest that ADHD is associated with a hyperactive dopamine
system due either to an elevated efflux of dopamine or a reduced
decrease in the reuptake of dopamine (34).
Results of recent longitudinal research have also shown that
the development of internalizing problems such as depression and
anxiety – largely through peer rejection – mediates the relationship
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between ADHD symptoms and risk for substance use and abuse
(15). Indeed, several studies have reported that depression and
anxiety disorders are the most frequently reported psychiatric co-
morbidities in those with ADHD [see Ref. (35)]. Such data suggest
that substance use, and other addictive behaviors, may be a form
of “self-medication” in the absence of adequate social support, and
as a means to cope with stressful events in adolescence. Together
these studies mesh with evidence that high-risk profiles for sub-
stance misuse include anxiety sensitivity, impulsivity, and high
sensation-seeking tendencies (36).
In the quest to better understand the mechanisms linking
ADHD symptoms to addictive behaviors, no mediational research
has examined whether stimulant-medication treatment for ADHD
affects the hypothesized associations among the variables of inter-
est. Moreover, the possible role of sex differences in moderating
these associations is untested. To address these issues, the cur-
rent study has employed a case-double-control design. Examin-
ing undiagnosed individuals with high-ADHD symptoms in the
general community, as well as stimulant-treated clinical cases of
ADHD, in relation to addictive behaviors removes the potential
confounding effects of medication status on outcome.
THE CURRENT STUDY
In this study, a moderated-mediation analysis was used to test our
prediction that a composite index of personality risk – including
impulsivity traits, reward sensitivity, and anxiety proneness –
mediates the relationship between ADHD symptomatology on the
one hand, and a general tendency toward engaging in addictive
behaviors on the other. We also predicted that sex would mod-
erate these relationships with males showing higher scores on
all the measured variables compared to females (see Figure 1).
These associations were assessed in three groups of young adult
men and women: those with a previous or current diagnosis of
ADHD who had been (or were currently being) treated with
a stimulant medication (e.g., methylphenidate); a high-ADHD-
symptom group; and, a low-ADHD-symptom group, both with
no lifetime diagnosis of, or stimulant treatment for, ADHD. It was
Personality
Risk Factors
ADHD Status
Sex/Gender
Addictive Behaviors
with mediator
ADHD Status Addictive Behaviors
without mediator
Sex/Gender
C
C’
A B
FIGURE 1 | Moderated-mediation model predicting that a
personality-risk index mediates the relationship between ADHD status
and a composite measure of addictive behaviors, and that sex
moderates these associations.
anticipated that the cases would have higher scores on all the mea-
sured variables in the analyses compared to the high-symptom
control group, who, in turn, would have higher scores than the
low-symptom controls.
MATERIALS AND METHODS
PARTICIPANTS
A sample of young men (n= 98) and women (n= 116) between
the ages of 17 and 32 years were recruited from the community
of a large Canadian university (student enrollment is ≈55,000,
with an additional 7000 faculty and staff employed on campus).
Mean ages (and SD) of the participants were 22.5 (3.3) and 22.2
(3.3) years, for males and females, respectively. Among these indi-
viduals, 46 (men= 25; women= 21) had received a diagnosis of
ADHD, and were either currently being treated with stimulant
medications or had been in the past. The prescribed medications
were Concerta, Ritalin, Vyvanse, Adderall, and Dexedrine. Partici-
pants were required to be fluent in written and spoken English and
to have lived in North America since childhood. Exclusion criteria
included a current diagnosis of an addiction disorder and a current
or lifetime diagnosis of a psychotic disorder using an abbrevi-
ated (non-patient) version of the structured clinical interview for
DSM-IV (SCID).
MEASURES
ADHD status
ADHD status was established by participant self-report, each of
whom was asked whether they had ever had a medical diag-
nosis of ADHD. If they answered in the affirmative, they were
asked at what age the diagnosis took place and whether they were
ever prescribed (and took) stimulant medication as part of their
treatment protocol. If stimulants were taken, the participant was
asked for the length and dates of the treatment, and for the name
of the prescribed medication. Approximately half of the ADHD
group was still on stimulant medication at the time of study
participation, while the other half had a prior history of phar-
macotherapy with stimulants, but was no longer receiving treat-
ment at the time of recruitment. The non-diagnosed participants
were dichotomized into a high-ADHD-symptom group (n= 83:
females= 53) and a low-symptom group (n= 84: females= 41)
based on a median split of their scores on the well-validated Con-
nors Adult ADHD Rating Scale (CAARS) (37). The self-report
measure was employed, which evaluates the presence and sever-
ity of ADHD symptoms. The scale comprises 30 items that are
rated on a four-point scale based on the frequency and severity of
ADHD inattentive and hyperactive/impulsive symptoms (0= not
at all, 1= just a little, 2= pretty much, and 3= very much). In the
present study, the total score was used and a median split of the
data from the non-ADHD participants was used to define the low-
and high-symptom groups.
Personality risk
Personality risk was modeled as a latent variable comprising three
personality factors associated with impulsive and rash responding,
and with anxiety proneness: (i) Impulsivity was assessed by the
well-validated 30-item Barratt Impulsivity Scale (BIS) (38), which
identifies facets of impulsivity such as the non-planning aspects
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of this construct, as well as the tendency to act rashly and to make
quick decisions. The alpha coefficient in this study was 0.77; (ii)
Reward Sensitivity was assessed by the Reward subscale (RS) of the
Sensitivity to Punishment and Sensitivity to Reward Questionnaire
(SPSRQ) (39). This scale comprises 24 forced-choice items reflect-
ing the respondent’s approach responses under various conditions
of reward. This scale was developed to assess the behavioral activa-
tion system (BAS) of Gray’s psychobiological model of personality
(40, 41). The alpha coefficient for the present study was 0.78; and
(iii) Addictive Personality Traits were assessed by the 32-item Addic-
tion Scale (AS) of the Eysenck Personality Questionnaire-Revised
(EPQ-R) (42). This scale was derived empirically by identifying
those items of the EPQ-R, at or beyond the 0.001 level of signif-
icance – and irrespective of subscale – which differentiated male
drug addicts from normal controls (43). In addition to studies
with drug addicts (44), this scale has been validated with groups
of problem drinkers (45), pathological gamblers (46), and those
with anorexia nervosa, bulimia nervosa, and binge eating disorder
(47, 48). The scale items are weighed toward the impulsive traits,
as well as anxiousness and negative affect. The alpha coefficient in
the present study was 0.81.
The three variables described above were moderately corre-
lated, as expected (r between 0.33 and 0.41; all p-values<0.0001).
A composite score was therefore calculated using principal com-
ponent analysis, as described in the Section “Results.”
Addictive behaviors
Addictive behaviors were assessed by the Shorter PROMIS Ques-
tionnaire (49), a self-report instrument for the concurrent mea-
surement of 16 addictive and/or excessive behaviors. Each subscale
comprises 10 statements that the respondent endorses on a 6-
point scale from 0 (“not like me”) to 5 (“like me”). The items
for each scale reflect the common characteristics of addictive
behaviors, such as use for effect, protection of supply, preoc-
cupation, using more than intended and increased capacity or
tolerance. For the purpose of the current study, a total score
was created by summing the items for the following seven
subscales: caffeine, recreational drugs, sex, nicotine, food bing-
ing, shopping/spending, and alcohol. Other subscales such as
“compulsive helping – dominant/submissive” and “relationship –
dominant/submissive” were deemed insufficiently related to con-
ventional addiction disorders to be included in the aggregate
score.
PROCEDURES
Participants were recruited by posters placed around the university
campus, by newspaper advertisements, and by means of targeted
announcements in online student forums. An initial screening
took place during a short telephone interview. An appointment
was made for a 1-h meeting in the university research laboratory
of the first author for participants who appeared to meet the eli-
gibility criteria. One the day of testing, informed consent and all
relevant demographic and clinical information was obtained dur-
ing a face-to-face interview. After the questionnaire package was
completed, height and weight were measured with the participant
standing in stocking feet and wearing light indoor clothing. At
the completion of the study, each participant was paid $15.00 to
cover out-of-pocket expenses. All study procedures were carried
out according to the Declaration of Helsinki.
STATISTICAL ANALYSES
The moderated-mediation model described in the Section “Intro-
duction” was analyzed using the four-step procedures described
by Baron and Kenny (50). According to this approach, mediation
is present when the following conditions are met: (i) the indepen-
dent categorical variable (ADHD status) is significantly related to
the proposed mediator (personality risk), shown as path A in the
model (see Figure 1); (ii) the proposed mediator (personality risk)
is significantly related to the dependent variable (addictive behav-
iors), shown as path B in the model; (iii) the independent variable
(ADHD status) is significantly related to the dependent variable
(addictive behaviors), shown as path C in the model; and (iv)
the relationship between ADHD status and addictive behaviors is
substantially minimized – or becomes non-significant – when the
proposed mediator (personality risk) is added as a covariate in
the analysis of variance (ANOVA) analysis described in the third
step. Sex was included as a potential moderator variable in the
first, third, and fourth ANOVA analyses described above. Moder-
ation is found if the ADHD status× sex interaction is statistically
significant.
RESULTS
As a preliminary analysis, independent t -tests were used to assess
group differences between the currently medicated and the pre-
viously medicated ADHD participants on all the quantitative
variables used in this study. Since there were no significant dif-
ferences between the groups, they were combined into a single
group for all subsequent analyses.
Table 1 presents the means and SD for all quantitative variables
included in the analyses, as well as for age and BMI, listed separately
for the three ADHD-status groups (i.e., those with a diagnosis of
ADHD, the high-symptom control group, and the low-symptom
control group). The groups did not differ from each other on
BMI. However, the low-symptom group was significantly older
than the high-symptom (p= 0.033) and the ADHD (p= 0.008)
groups, who did not differ from each other. Although statistically
significant in our sample, an age difference of 1–2 years in young
Table 1 | Means and SD for all quantitative variables listed separately
for the three ADHD status groups.
Variable ADHD High-symptom Low-symptom
Mean SD Mean SD Mean SD
Age 21.5 2.7 22.0 3.3 23.1 3.3
BMI 25.8 4.4 25.4 6.7 24.2 4.7
CAARS total score 41.4 20.6 40.0 11.3 15.3 6.4
Barrett impulsivity
scale
71.3 14.9 67.3 11.5 55.7 7.8
Reward sensitivity 12.5 4.3 13.5 4.2 10.4 4.3
Addictive personality
traits
13.3 6.2 14.5 4.7 9.8 4.4
Addictive behaviors 71.0 60.0 64.0 35.2 42.8 29.5
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adulthood was not considered clinically relevant in the context
of our research. With respect to the classification variable for the
control groups (viz. symptom scores as assessed by the CAARS),
the ADHD group had significantly higher scores than the low-
symptom group (p< 0.0001). Surprisingly, there was no difference
between the ADHD groups and the high-symptom control group
(p= 0.456).
In order to create a latent variable reflecting personality risk,
a composite score was calculated for the three personality vari-
ables (BIS, RS, and AS) using a principal component analysis.
The extracted component accounted for 58% of the variance in
the three personality scales, and all three loaded strongly on this
factor (loadings ranged from 0.73 to 0.79).
MODEL TESTING
Path A
Path A was tested using a 3 (ADHD status)× 2 (Sex) ANOVA
with personality risk as the dependent variable. There was a sig-
nificant main effect for ADHD status. Post hoc comparisons using
the least significant difference (LSD) test indicated that the low-
symptom group had significantly lower personality-risk scores
than the ADHD group (p< 0.0001) and the high-symptom group
(p< 0.0001), which did not differ from each other (p= 0.634).
Neither the main effect for sex nor the AHDH status× sex inter-
action was statistically significant. Table 2 presents the summary
statistics for these analyses.
Path B
Path B was tested by regressing addictive behaviors on the
personality-risk factor score, and results indicated a significant
positive association between the two variables (see Table 3).
Path C
Path C (without the mediating variable) was tested using a 3
(ADHD status)× 2 (sex) ANOVA with addictive behaviors as the
Table 2 | Summary statistics for the 3×2 ANOVA with the
personality-risk factor score as the dependent variable.
Source df Mean squares F p-value
Intercept 1 0.7 0.89 0.346
ADHD status 2 23.7 31.80 <0.0001
Sex 1 0.3 0.45 0.502
ADHD status× sex 2 1.0 1.40 0.249
Error 203 0.7
Total 209
Table 3 | Unstandardized coefficients for the regression analysis with
addictive behaviors as the dependent variable and the
personality-risk factor score as the independent variable.
Variable B SE t (Ho) p
Intercept 57.4 2.3 25.11 <0.0001
Personality risk 25.5 2.3 11.14 <0.0001
R 2 =0.38.
dependent variable. There was a significant main effect for ADHD
status. Post hoc comparisons using the LSD test again indicated
that the low-symptom group had significantly lower scores on the
addictive-behaviors variable than the ADHD group (p< 0.0001)
and the high-symptom group (p= 0.001), which did not differ
from each other (p= 0.348). Neither the main effect for sex nor the
AHDH status× sex interaction was statistically significant. Table 4
presents the summary statistics for these analyses.
Path C ′
In the final step, Path C ′ was tested by repeating the analysis
described in Section “Path C”; however, this time the proposed
mediator (personality risk) was included as a covariate in the
model. Results indicated that personality risk was a highly sig-
nificant predictor in the model, but that the ADHD status main
effect no longer contributed significantly to the variance in addic-
tive behaviors. There was no main effect for sex, nor was the ADHD
status× sex interaction statistically significant (Table 5).
SUPPLEMENTARY ANALYSES
Although we selected an aggregate index in this study to reflect
a general proclivity for addictive behaviors, we also expect that
some readers may be interested in the statistical outcome for each
individual addictive behavior. The following provides a summary
of these results, and should be viewed as information supplemen-
tary to the original hypothesis-driven analyses. Table 6 presents
the means and SD for each of the seven addictive behaviors,
listed separately for the ADHD status groups and for men and
women. To assess group differences, we employed a 3 (ADHD
status) by 2 (sex) multivariate analysis of variance (MANOVA)
with the individual addictive variables as dependent variables.
Table 4 | Summary statistics for the 3×2 ANOVA with the addictive
behaviors as the dependent variable.
Source df Mean squares F p-value
Intercept 1 664358.0 418.34 <0.0001
ADHD status 2 13642.9 8.59 <0.0001
Sex 1 2292.1 1.44 0.231
ADHD status× sex 2 1073.1 0.68 0.510
Error 206 1588.1
Total 212
Table 5 | Summary statistics for the 3×2 ANOVA with addictive
behaviors as the dependent variable and the personality-risk factor
score as a covariate in the model.
Source df Mean squares F p-value
Intercept 1 614323.1 569.3 <0.0001
Personality risk 1 107627.9 99.34 <0.0001
ADHD status 2 1352.7 1.2 0.288
Sex 1 984.3 0.91 0.341
ADHD status× sex 2 2571.5 2.38 0.095
Error 201 1079.12
Total 208
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Table 6 | Means and SD for seven addictive-behaviors subscales of the
PROMIS questionnaire, listed separately for the three ADHD status
groups and for sex.
Variable ADHD High-symptom Low-symptom
Mean SD Mean SD Mean SD
Female
Caffeine 3.9 5.1 3.9 4.6 1.5 2.8
Recreational drugs 12.9 18.5 3.3 7.1 2.3 5.6
Sexual activities 7.2 13.9 3.8 8.6 2.3 6.1
Nicotine 8.6 14.6 2.6 8.4 1.9 6.1
Food binging 13.2 13.6 16.0 9.8 12.3 6.1
Alcohol 9.0 10.4 9.7 10.7 8.3 9.3
Shopping/spending 13.9 12.5 17.0 9.9 13.6 9.4
Male
Caffeine 4.7 7.8 5.9 7.4 4.9 6.9
Recreational drugs 12.4 15.4 7.2 10.7 3.8 7.4
Sexual activities 10.3 13.7 9.9 9.5 6.4 8.2
Nicotine 8.2 15.4 6.6 11.7 2.1 6.2
Food binging 10.0 10.0 14.9 8.1 6.8 6.1
Alcohol 15.4 11.4 15.4 11.0 11.2 8.8
Shopping/spending 10.8 9.8 11.5 8.6 8.3 7.2
The multivariable Wilks’ Lambda F ratios were statistical signifi-
cant for ADHD status and for sex (F 14,400= 3.33; p< 0.0001, and
F 7,200= 7.12; p< 0.0001, respectively). However, the main-effects
interaction term did not reach statistical significance. Results of
the univariate results are provided below.
Caffeine intake, alcohol consumption, and shopping/spending
For these three variables, there were no main effects for ADHD sta-
tus. However, males had a higher frequency of caffeine (p= 0.01)
and alcohol (p= 0.01) consumption compared to females, while
females were more prone to compulsive shopping (p= 0.001).
Recreational drugs and nicotine
In contrast, for these two addictive behaviors there were no main
effects for sex. There were, however, significant main effects for
ADHD status (p< 0.0001 and 0.002, respectively). Post hoc com-
parisons using the LSD procedure indicated that for recreation
drug use, the ADHD group had significantly higher scores than
both the low- and the high-symptom groups (p< 0.0001 in each
case), who did not differ significantly from each other. With respect
to nicotine, similar results were found with the ADHD group
having higher scores than the high-symptom (p= 0.026) and the
low-symptom (p< 0.0001) groups, who again were not different
from each other.
Food binging and sexual activity
For these two variables, there was a significant additive effect
of ADHD status (p= 0.001 and 0.045, respectively) and sex
(p= 0.025 and 0.002, respectively). Not surprisingly, woman
had higher scores on food binging than men, while the reverse
was found for sexual activity. Concerning food binging, the
high-symptom group had more elevated scores than either the
low-symptom (p= 0.001) or the ADHD groups (p= 0.027), who
did not differ from each other. And finally, the low-symptom group
had reduced scores on the sexual-activity variable compared to the
high-symptom (p= 0.037) and the ADHD (p= 0.004) groups,
who were not significantly different from each other.
DISCUSSION
Results of our moderated-mediation analysis suggest that a com-
posite index of personality risk – reflecting aspects of impulsivity
and reward drive, as well as neurotic and anxiousness traits – may
mediate the positive relationship between ADHD symptomatol-
ogy and addictive behaviors. In other words, these findings suggest
that the personality traits frequently found in those with ADHD
may be the underlying mechanism driving their preference for,
and proneness to engage in, activities with immediately reinforc-
ing qualities and outcomes. Unexpectedly, however, there were
no differences between the ADHD group and the high-symptom
participants on the composite measure of addictive behaviors,
although both groups had significantly higher scores than the
low-symptom group1. We also found that the ADHD and the
high-symptom group had virtually identical scores on the ADHD-
symptom variable (viz. the CAARS), which is used clinically as a
diagnostic tool, and was employed in this study to dichotomize the
sample into high- and low-symptom control groups. The findings
described here suggest that stimulant medication (either current
or past) does not appear to enhance or diminish the general like-
lihood of engaging in addictive activities. In essence, these results
appear to be in accord with recent research showing no evidence
of a “sensitization” effect of stimulant treatment in those with
a lifetime diagnosis of ADHD (17). Such conclusions, however,
must be interpreted with caution since the sample of participants
with ADHD was not of sufficient size to control for factors such
as length of stimulant treatment, age of onset, and medication
dosage.
The absence of clinically relevant symptom differences between
the ADHD and the high-symptoms groups may suggest that the
former was more high-functioning than is typical of the general
population of young adults with ADHD (or a history thereof).
Indeed, this possibility gains credibility since most of the ADHD
participants in our study were recruited from the student body of
a local university. On the other hand, a recent survey of childhood
impairments in those with and without ADHD – based on retro-
spective adult recall – found that while the ADHD group reported
1When each addictive behavior was considered separately – as seen in the Section
“Supplementary Analyses” – recreational drug use and cigarette smoking were sig-
nificantly higher in the ADHD group than in either of the control groups, who did
not differ from each other. Moreover, there were no group differences regarding
alcohol consumption. It is interesting to note that the nicotine and alcohol results
in the current study are in close accord with previous findings reported in the
Section “Introduction” (14, 15). With regard to food binging, the finding that the
high-symptom group had significantly elevated scores, compared to the ADHD or
low-symptoms groups, is difficult to explain. Given that half of the ADHD group
was currently on stimulant medication, and in light of recent evidence that stimu-
lants are effective in reducing binge-eating episodes (51), it may be that the relatively
low scores in the ADHD group were the result of medication effects. Importantly,
however, and similar to results with the addictive-behaviors composite score, there
was no ADHD status× sex interaction for any of the individual variables.
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more school difficulties compared to controls, there were no differ-
ences in their respective levels of educational attainment (35). Such
data imply, therefore, that university recruitment does not neces-
sarily create a biased sample in relation to the severity of ADHD
symptomatology. Another possible explanation for the absence of
differences between the ADHD and the high-symptom groups is
that stimulant treatment for the former may have ameliorated their
symptom severity. On the other hand, the absence of differences
may also indicate that ADHD is relatively under-diagnosed among
apparently healthy adults who have high-ADHD symptoms.
It was of considerable interest to find no differences in the mag-
nitude of the personality-risk index between those with AHDH
and the high-symptom group, although again both had signifi-
cantly higher scores than the low-symptom group. The composite
personality variable – created for the current study as a marker
of risk for addictive behaviors – is not only validated empiri-
cally by our results but also complements previous research in
this area. For instance, both novelty seeking and harm avoidance
were significantly greater in a large group of patients with opiate
addiction and/or alcohol dependence compared to normal con-
trols (52). Individuals with a compulsive buying disorder also had
more symptoms of ADHD, as well as lifetime mood, anxiety, and
impulse control disorders, compared to an appropriate control
group (53). Additionally, the compulsive buyers had more pro-
nounced personality traits related to depression, impulsivity, and
novelty seeking (an aspect of high-reward sensitivity).
Contrary to expectations, and after controlling for ADHD sta-
tus in our analyses, there were no male–female differences in
personality risk, nor in the use of addictive behaviors; neither
did sex moderate the relationships tested in our mediation model.
Concerning the addictive-behaviors variable – and in light of our
findings that individual differences in risk were not sex-specific – it
may be that sex differences were washed out because we oper-
ationalized addictive behaviors as an aggregate index of several
activities, both substance and non-substance related. Some addic-
tive behaviors, like compulsive buying (54) and binge eating (55),
are more frequently found in women, while others like hypersexual
behaviors tend to be more common in men (56)2.
In conclusion, strengths of this study are the inclusion of a
non-diagnosed and non-treated group of young adults with high-
ADHD symptom severity equivalent to the group of clinically
diagnosed ADHD participants. In addition, we also included a
low-symptom control group, thereby providing a double con-
trol for the clinical cases. Our focus on both mediating and
moderating factors in connection to the ADHD-addictive behav-
iors link is another strong point of this research. The use of a
2Indeed, results from the post hoc Supplementary Analyses did demonstrate that
women had higher scores than men on the binge-eating and compulsive-shopping
variables, as seen in previous research (54, 55). We also found, as others have, that
men had higher scores than women on sexual addiction (56) and alcohol consump-
tion (57). With respect to caffeine, our findings showed that men also had higher
scores than women. While very few studies have examined sex/gender differences
in caffeine consumption, one early report indicated that adolescent boys found the
reinforcing effects of caffeine greater than girls did, suggesting that the former may
be more prone to consume caffeinated beverages (58). Important, however, is that
sex did not moderate the relationship between ADHD status and addictive behaviors
whether we used the composite index or the individual sub-scale scores.
composite dependent-variable index of addictive behaviors also
provided a more comprehensive approach than one which exam-
ined each addictive activity separately (although these data have
been provided as supplementary information). This strategy is
particularly relevant since preferences for specific addictive activ-
ities are known to vary across sociocultural groups (59–61). In
addition, while other studies have examined personality corre-
lates of ADHD – in particular, those also associated with risk
for addiction – as reviewed in the Section “Introduction,” this
body of work has largely investigated constructs related to impul-
sive responding. The current study has extended this research by
using a multivariate approach to operationalize personality risk
by forming of composite latent variable including facets of impul-
sivity, reward sensitivity, and anxiousness. We have also moved
beyond the investigation of simple relationships by employing
moderated-mediation procedures in our data analyses.
However, despite the merits of our current research, it is also
important to address the limitations of the study. Foremost is
the fact that the ADHD participants comprised two distinct sub-
groups – those who were currently on stimulant medication and
those who had been, but were no longer, taking these drugs.
While our data indicated that the two groups did not differ on
the variables included in this study, these analyses may have been
under-powered by virtue of relatively small sample sizes. Another
constraint of the study is that the associations we observed were
based on cross-sectional data, thereby limiting our ability to infer
directional relationships between symptoms and behaviors. While
it is intuitive, for example, to suppose that ADHD symptoms con-
tribute to the use and abuse of addictive behaviors, it is also known
that chronic use of addictive substances/activities can foster some
of the symptoms that define ADHD such as poor impulse control
(62). Only longitudinal research will be able to establish causal
mechanisms between ADHD symptoms and addiction, and the
mediating role of personality-risk factors.
To summarize, we found that a high-risk personality profile
may, in part, account for the relationship between ADHD symp-
tomatology and the use/abuse of a broad range of addictive behav-
iors. We also found no evidence that current or past treatment of
ADHD symptoms with stimulant medication increases the prob-
ability of engaging in potentially addictive activities. While there
is good evidence that ADHD is more prevalent in males than in
females (63), we found no sex differences in personality risk for
addiction or in the use of addictive behaviors; nor did sex mod-
erate the relationships we assessed. The mediational impact of
personality-risk factors found in our study has important clinical
implications, especially in light of recent evidence from a ran-
domized control trial, demonstrating that a personality-targeted
prevention program for adolescence was significantly more effec-
tive in reducing alcohol use and misuse than a standard and
statutory drug-education program (36).
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